MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
0.8800
+0.1000
+12.82%
Pre Market: 0.8251 -0.0549 -6.24% 08:16 03/09 EDT
OPEN
0.7500
PREV CLOSE
0.7800
HIGH
0.8850
LOW
0.7500
VOLUME
2.16K
TURNOVER
0
52 WEEK HIGH
2.390
52 WEEK LOW
0.6765
MARKET CAP
7.19M
P/E (TTM)
-1.7632
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMRN last week (0302-0306)?
Weekly Report · 2h ago
Emerging Growth Research reiterates Buy-Extended on Immuron with $3.90 price target
Reuters · 3d ago
Immuron CEO Steven Lydeamore to Present Virtually at Coffee Microcaps Conference
Reuters · 4d ago
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
Barchart · 4d ago
Immuron HY26 net loss narrows 22.9% to AUD 1.9 million
Reuters · 03/02 11:10
Weekly Report: what happened at IMRN last week (0223-0227)?
Weekly Report · 03/02 10:11
Immuron H1 EPS $(0.01), Same YoY, Sales $4.184M Up From $3.994M YoY
Benzinga · 02/25 13:26
Immuron reports 1H results
Seeking Alpha · 02/25 11:14
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.